1-10 of 10
Anna-Katharina Zoellner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Stefan Alig, MD, Alessandro Pastore, Vindi Jurinovic, Sarah Häbe, Deepak Bararia, PhD, Verena Passerini, PhD, William Keay, Johannes Hellmuth, Andreas Rosenwald, Wolfram Klapper, MD, Harald Stein, MD PhD Dr. h.c., Alfred Feller, German Ott, MD, Annette M. Staiger, PhD, Heike Horn, Martin-Leo Hansmann, Christiane Pott, Roswitha Forstpointner, Wolf-Karsten Hofmann, Norbert Schmitz, MD, Georg Hess, Michael Unterhalt, Martin H. Dreyling, MD PhD, Anna-Katharina Zoellner, Christian Schmidt, MD, Eva Hoster, Wolfgang Hiddemann, Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2018-99-118000
Published: 2018
Journal Articles

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Christian Schmidt, MD, Anna-Katharina Zoellner, Vindi Jurinovic, Martin Sökler, MD, Roswitha Forstpointner, Sascha Haubner, MD, Christian Buske, MD, Andreas Viardot, MD, Ulrich Keller, Christiane Pott, Ullrich Graeven, MD, Reinhard Marks, Mathias Hänel, MD, Ruediger Liersch, Jan Dürig, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2018) 132 (Supplement 1): 448.
https://doi.org/10.1182/blood-2018-99-111692
Published: 2018
Journal Articles

Alternative Donor Transplantation Using Intensified Conditioning, T-Cell-Replete HLA-Haploidentical Grafts and Post-Transplantation Cyclophosphamide in the Treatment of High-Risk and Advanced ALL: Feasibility and Outcome

Anna-Katharina Zoellner, MD, Dusan Prevalsek, MD, Thomas Köhnke, MD, Susanne Fritsch, MD, Christoph Schulz, MD, Max Hubmann, MD, Stephanie Lippl, Stephan Kruger, Sarah Häbe, Sophie Berking, Alessia Fraccaroli, Georg Ledderose, MD, Hans-Joachim Stemmler, MD, Karsten Spiekermann, MD, Wolfgang Hiddemann, MD, Gesine Bug, MD, Andreas Hausmann, MD, Christoph Schmid, MD, Michael H. Albert, MD, Johanna Tischer
Journal: Blood
Blood (2016) 128 (22): 2224.
https://doi.org/10.1182/blood.V128.22.2224.2224
Published: 2016
Journal Articles

Feasibility and Outcome of Sequential Therapy in the Setting of HLA-Haploidentical Transplantation Utilizing Reduced-Intensity Conditioning, T-Cell-Replete Grafts and Post-Transplantation High-Dose Cyclophosphamide in the Treatment of High-Risk AML and MDS

Dusan Prevalsek, MD, Susanne Fritsch, MD, Max Hubmann, MD, Nicole Engel, MD, Anna-Katharina Zoellner, MD, Thomas Köhnke, MD, Veit Leonhard Bücklein, MD, Christoph Schulz, MD, Friederike Mumm, MD, Christina Theresa Rieger, MD, Georg Ledderose, MD, Hans-Joachim Stemmler, MD, Karsten Spiekermann, MD, Wolfgang Hiddemann, MD, Andreas Hausmann, MD, Johanna Tischer, MD
Journal: Blood
Blood (2015) 126 (23): 4318.
https://doi.org/10.1182/blood.V126.23.4318.4318
Published: 2015
Journal Articles

Combination of PI3K and PDPK1 Inhibitors Is Highly Effective in Mantle Cell Lymphoma

Grit Hutter, PhD, Yvonne Zimmermann, Anna-Katharina Zoellner, MD, Philip Irrgang, Oliver Weigert, MD, Wolfgang Hiddemann, MD, Martin Dreyling
Journal: Blood
Blood (2014) 124 (21): 3123.
https://doi.org/10.1182/blood.V124.21.3123.3123
Published: 2014
Journal Articles

Allogeneic Transplantation in Elderly Patients with AML and MDS Comparing Reduced-Intensity Conditioning with Flamsa-Busulfan Versus Fludarabine/BCNU/Melphalan

Nicole Engel, MD, Wolfgang Hill, MD, Susanne Fritsch, MD, Dusan Prevalsek, MD, Anna-Katharina Zoellner, MD, Max Hubmann, MD, Veit Buecklein, MD, Andreas Hausmann, MD, Georg Ledderose, MD, Hans-Jochem Kolb, PhD, Wolfgang Hiddemann, MD, Johanna Tischer, MD
Journal: Blood
Blood (2014) 124 (21): 5839.
https://doi.org/10.1182/blood.V124.21.5839.5839
Published: 2014
Journal Articles

High Efficiency Of the PDPK1-Inhibitor, BX912, In MCL

Grit Hutter, Yvonne Zimmermann, Vladimir Giller, Anna-Katharina Zoellner, Oliver Weigert, Wolfgang Hiddemann, M.D., Martin Dreyling
Journal: Blood
Blood (2013) 122 (21): 3077.
https://doi.org/10.1182/blood.V122.21.3077.3077
Published: 2013
Journal Articles

Rituximab But Not GA101 Is Partially Antagonistic With Inhibitors Of The B-Cell Receptor Pathway In Diffuse Large B-Cell Lymphoma

Anna-Katharina Zoellner, Nico Peter, Grit Hutter, Yvonne Zimmermann, Wolfgang Hiddemann, MD, Martin Dreyling
Journal: Blood
Blood (2013) 122 (21): 4420.
https://doi.org/10.1182/blood.V122.21.4420.4420
Published: 2013
Journal Articles

Sequential Therapy Combining Clofarabine and HLA-Haploidentical Hematopoietic Stem Cell Transplantation In The Treatment Of Refractory and Advanced Lymphoma: Feasibility, Toxicity and Early Outcome

Anna-Katharina Zoellner, Susanne Fritsch, MD, Dusan Prevalsek, MD, Nicole Engel, MD, Roland Reibke, MD, Christina T Rieger, MD, PhD, Georg Ledderose, MD, Wolfgang Hiddemann, MD, Martin Dreyling, Andreas Hausmann, MD, Johanna Tischer, MD
Journal: Blood
Blood (2013) 122 (21): 4544.
https://doi.org/10.1182/blood.V122.21.4544.4544
Published: 2013
Journal Articles

Differential Role of the B-Cell Receptor Pathway in Diffuse Large Cell B Cell Lymphoma: Temsirolimus Has Additive Effects in Combination with the BTK Inhibitor PCI-32765 and PI3K Inhibitor Cal101 but Antagonizes Bortezomib in GCB Subtype

Anna-Katharina Zoellner, Stephan Bayerl, Marc Weinkauf, Georg Hess, Wolfgang Hiddemann, MD, Martin H. Dreyling, PhD
Journal: Blood
Blood (2011) 118 (21): 1664.
https://doi.org/10.1182/blood.V118.21.1664.1664
Published: 2011